Visit | -1 Screening | 0 Baseline Start intervention | 1 End of intervention | 2 Follow-Up | 3 Follow-Up | 4 Final follow-up visit |
---|---|---|---|---|---|---|
Week | −12 (max) | 1 | 9 | 13 | 17 | 33 |
Informed consent | x | Â | Â | Â | Â | Â |
Demographics | x | Â | Â | Â | Â | Â |
Inclusion / exclusion criteria | x | x | x | x | x | x |
Case history | x | Â | Â | Â | Â | Â |
Medication | x | x | x | x | x | x |
DASH | Â | x | x | x | x | x |
SF-36 | Â | x | x | x | x | x |
VAS pain | Â | x | x | x | x | x |
Key pinch force | Â | x | x | x | x | x |
Goniometry | Â | x | x | x | x | x |
MHT | Â | x | x | Â | Â | Â |
TUS | Â | x | x | Â | Â | Â |
MHT + TUS |  | x | x |  |  |  |
Physical examination | x | Â | Â | Â | x | Â |
AE / SAE query | Â | x | x | x | x | x |